$1.660
-0.030 (-1.78%)收盤時
OSTX 同業比較
In the context of the broader market, OSTX competes directly with industry leaders such as GANX and LONA. With a market capitalization of $74.72M, it holds a significant position in the sector. When comparing efficiency, OSTX's gross margin of N/A stands against GANX's N/A and LONA's N/A. Such benchmarking helps identify whether OS Therapies Inc is trading at a premium or discount relative to its financial performance.
OS Therapies Inc 財務表現
The company has reported consistent net losses, with Q1 2026 showing a net operating loss of $10.4 million, a 167% increase from the previous year, indicating significant challenges in achieving profitability.
Financials
FY2026Q2
YoY:
+77.23%
-8.58M
Operating Profit
FY2026Q2
YoY:
+90.28%
-8.63M
Net Income after Tax
FY2026Q2
YoY:
+11.11%
-0.20
EPS - Diluted
FY2025Q4
YoY:
+57.09%
-3.73M
Free Cash Flow
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。